Anti-TNF-anti-IL-17 bispecific antibodies

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9416182
SERIAL NO

14195885

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Bispecific antibodies are provided that specifically bind both Tumor Necrosis Factor alpha (TNFα) and Interleukin-17 (IL-17). The bispecific antibodies of the invention are useful for treating various autoimmune diseases, including Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), and Ankylosing Spondylitis (AS).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • ELI LILLY AND COMPANY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Allan, Barrett Encinitas, US 17 631
Glasebrook, Andrew Lawrence San Diego, US 5 104
Leung, Donmienne Doen Mun San Diego, US 17 35
Lu, Jirong Carmel, US 36 245
Tang, Ying San Diego, US 106 741
Vendel, Andrew Charles Cardiff-by-the-Sea, US 4 12
Witcher, Derrick Ryan Fishers, US 30 95
Yachi, Pia Pauliina San Diego, US 4 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 16, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 16, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00